Evidence map›Paper›PMID 41185713›Full record

ArticleCureus2025

Incidental Atrial Myxoma in the Shadow of COVID-19: Coincidence or an Emerging Pattern?

Bilal Rashid, Isfandyar Baig, Muhammad Dawar Feroze, Manahil Chaudhry, Muhammad Sardar Zeeshan Hassan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bilal RashidAcute Medicine, Lancashire Teaching Hospitals National Health Service (NHS) Foundation Trust, Preston, GBR.
Isfandyar BaigGeneral Practice, Mersey and West Lancashire Teaching Hospitals National Health Service (NHS) Trust, Preston, GBR.
Muhammad Dawar FerozeGeneral Surgery, Shalamar Medical and Dental College, Lahore, PAK.
Manahil ChaudhryAcute Medicine, Lancashire Teaching Hospitals National Health Service (NHS) Foundation Trust, Preston, GBR.
Muhammad Sardar Zeeshan HassanEmergency Medicine, Combined Military Hospital, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cardiac tumours are a rare entity, and atrial myxomas are a benign subtype usually found in the left atrium. They can present with a wide array of symptoms ranging from cardiac complications to systemic emboli. On the contrary, they can also manifest silently and are detected incidentally, as in this case of an 83-year-old female patient. New lung changes on an X-ray done as a part of an infection screen ultimately led to the diagnosis of an atrial myxoma confirmed by a transthoracic echocardiogram (TTE) and a transoesophageal echocardiogram (TOE). The patient was commenced on anticoagulation and was referred for cardiac surgery. Notably, she had suffered a COVID-19 infection recently, which may have acted as a catalyst in the formation of the tumour. Although a direct causal relationship cannot be established, the literature suggests that COVID-19 infection may lead to chronic inflammation, immune dysregulation, endothelial dysfunction, and other direct viral effects on tissues, all of which could potentially contribute to tumour formation.

Indexed as

cardiac endothelitiscardiac tumourcovid-19left atrial myxomasilent myxoma

Identifiers

PMID41185713
PMCPMC12579743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.